Searched for
DRUG APPROVALS INDIA
Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
Chandipura virus claims 22 lives in Gujarat: Why children are most vulnerable, what parents should watch for, symptoms, treatment and government actionGujarat health officials reported twenty-two deaths and thirty-five Chandipura virus cases. Seven patients remain in intensive care units r...
IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...
Govt weighs PLI 2.0 with sharper focus on high-performing sectorsIndia is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...
Flying from India to the UAE? Know these baggage restrictions on food, medicines and other itemsTravelers from India to the UAE must check airline and customs regulations before packing. Certain food items like copra and poppy seeds ar...
GLP-1 demand stirs up hunger for obesity care talentDemand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...
Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
Centre readies healthcare compliance overhaul to boost hospitals in tier-2, tier-3 citiesIndia plans major healthcare regulatory changes soon. These reforms aim to simplify licensing and reduce compliance burdens. The govt will ...
US FDA approves world's first oral cholesterol-lowering pill: What it means for patientsThe FDA has approved Lipfendra, an oral PCSK9 inhibitor, for high cholesterol. This new once-daily pill offers an alternative to injectable...
Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
Parliament watch: FTA exports rise, PLI payouts growIndia's merchandise exports to its free trade agreement (FTA) partner countries rose 25% year-on-year to $43.14 billion in the April-June q...
Govt disburses Rs 35,354 crore as on March 31 under PLI schemes: Jitin PrasadaProduction Linked Incentive schemes, which aim to boost manufacturing and attract significant investments, have disbursed Rs 35,354 crore t...
Akums to acquire Oriflame India's manufacturing businessAkums Drugs and Pharmaceuticals will acquire Oriflame India's manufacturing business. This significant deal is valued at fifty-six crore ru...
Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...